Showing results (761-770 of 861) with videos related to
Sort By:
Pageof 87
Circulation|March 14, 1998
Risk factors for in-hospital nonhemorrhagic stroke in patients with acute myocardial infarction treated with thrombolysis: results from GUSTO-IK W Mahaffey, C B Granger, M A Sloan, et al.International Journal of Oncology|February 7, 2012
Identification of blood protein biomarkers that aid in the clinical assessment of patients with malignant gliomaBaogang J Xu, Qi A An, Supriya Srinivasa Gowda, et al.Trials|March 17, 2021
Napping on the night shift and its impact on blood pressure and heart rate variability among emergency medical services workers: study protocol for a randomized crossover trialP Daniel Patterson, Leonard S Weiss, Matthew D Weaver, et al.Biorxiv : the Preprint Server for Biology|May 15, 2024
Velociraptor: Cross-Platform Quantitative Search Using Hallmark Cell FeaturesClaire E Cross, Cass Mayeda, Stephanie Medina, et al.Biorxiv : the Preprint Server for Biology|January 13, 2025
Cxcl10 is required for survival during SARS-CoV-2 infection in miceShamik Majumdar, Joseph D Weaver, Sergio M Pontejo, et al.Journal of Leukocyte Biology|November 28, 2024
Cxcl10 is protective during mouse-adapted SARS-CoV-2 infectionShamik Majumdar, Joseph D Weaver, Sergio M Pontejo, et al.American Heart Journal|September 1, 1999
Neurosurgical evacuation of intracranial hemorrhage after thrombolytic therapy for acute myocardial infarction: experience from the GUSTO-I trial. Global Utilization of Streptokinase and tissue-plasminogen activator (tPA) for Occluded Coronary ArteriesK W Mahaffey, C B Granger, M A Sloan, et al.Journal of Public Health Management and Practice : JPHMP|July 23, 2024
Rapid Online Data Collection and Reporting to Local Health Departments during the Pandemic: The COVID-19 Outbreak Public Evaluation (COPE) Initiative SARS-CoV-2 Case SurveysLauren A Booker, Mark É Czeisler, Rashon I Lane, et al.European Heart Journal|April 2, 2002
Clinical characteristics and outcome of patients with early (4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarctionF Zijlstra, A Patel, M Jones, et al.American Heart Journal|September 29, 1999
Efegatran sulfate as an adjunct to streptokinase versus heparin as an adjunct to tissue plasminogen activator in patients with acute myocardial infarction. ESCALAT InvestigatorsA Y Fung, G Lorch, P A Cambier, et al.Pageof 87